Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group studyShaji Kumar, Philippe Moreau, Xavier Leleu et al.|Leukemia|2011Cited by 721
Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytomaRichard Soutar, Diana Samson, Helen Lucraft et al.|British Journal of Haematology|2004Cited by 447
Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytomaRichard Soutar, Diana Samson, Helen Lucraft et al.|Clinical Oncology|2004Cited by 238
UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M‐proteins and the management of monoclonal gammopathy of undetermined significance (MGUS)Jenny Bird, Eric Low, Judith Behrens et al.|British Journal of Haematology|2009Cited by 137
Time to redefine MyelomaGuy Pratt, Jenny Bird, Stella Bowcock et al.|British Journal of Haematology|2015Cited by 17